Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Richard D. Beger

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Branch Chief

Also affiliated: Wesleyan University (1995–1998); University of Hawaiʻi at Mānoa (2006–2007); United States Department of Health and Human Services (2009); National Institutes of Health (2000); United States Food and Drug Administration (1999–2026); Center for Drug Evaluation and Research (2020); University of Wisconsin–Madison (1999); Johns Hopkins University (1993); Kangwon National University (2006–2007); Purdue University West Lafayette (1989–1992); Johns Hopkins Medicine (1993); United States Public Health Service (2000); National Institute of Environmental Health Sciences (2000); National Cerebral and Cardiovascular Center (2007); Chugai Research Institute For Medical Science, Inc. (Japan) (2007); Obihiro University of Agriculture and Veterinary Medicine (2007); University of Pennsylvania (1999); University of Birmingham (2016); Kumamoto University (2007)

49 h-index 218 pubs 14,465 cited

  • Animals
  • Humans
  • Magnetic Resonance Spectroscopy
  • Metabolomics
  • Male
  • Biomarkers
  • Female
  • Rats
  • Liver
  • Chemical and Drug Induced Liver Injury
  • Quantitative Structure-Activity Relationship
  • Mass Spectrometry
  • Chromatography, High Pressure Liquid
  • Rats, Sprague-Dawley
  • Models, Molecular

Biography and Research Information

OverviewAI-generated summary

Richard D. Beger, Branch Chief at the National Center for Toxicological Research, focuses on the application of metabolomics in toxicology and precision medicine. His research has explored the development of reporting standards for chemical analysis and data analysis in metabolomics. He has investigated the role of metabolomics in discovering biomarkers for drug-induced hepatotoxicity and nephrotoxicity. His work also includes studies on the metabolic pathways involved in biological processes, such as the isolation of human intestinal bacteria metabolizing isoflavone glycosides and the deletion of LOX-1 in reducing atherogenesis in mice fed a high-cholesterol diet.

Beger has contributed to collaborative projects, including the Collaborative Estrogen Receptor Activity Prediction Project (CERAPP). His scholarly output is substantial, with a high-impact designation reflected in his h-index of 49, over 220 publications, and more than 14,000 citations. His recent activity indicates continued engagement in research, with the most recent publication listed as 2026. Key collaborators include Jinchun Sun, Lisa Pence, Amy L. Inselman, and Kellie A. Woodling, all from the National Center for Toxicological Research.

Metrics

  • h-index: 49
  • Publications: 218
  • Citations: 14,465

Positions

  • Branch Chief 1998–present
    National Center for Toxicological Research Division of Systems Biology ORCID

Selected Publications

  • Assessing the developmental effects of fentanyl and impacts on lipidomic profiling using neural stem cell models (2025)
    Experimental Biology and Medicine 2 citations DOI OpenAlex
  • Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop (2025)
    Journal of Allergy and Clinical Immunology 3 citations DOI OpenAlex
  • Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers (2024)
    Metabolomics 4 citations DOI OpenAlex
  • The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses (2024)
    Frontiers in Toxicology 1 citation DOI OpenAlex
  • Analysis types and quantification methods applied in UHPLC-MS metabolomics research: a tutorial (2024)
    Metabolomics 41 citations DOI OpenAlex
  • Identification of Proteomic Biomarkers of Acetaminophen-Induced Hepatotoxicity Using Stable Isotope Labeling (2024)
  • The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model (2024)
    Frontiers in Pharmacology 2 citations DOI OpenAlex
  • Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples (2023)
    Analytical Chemistry 124 citations DOI OpenAlex
  • Metabolomics evaluation of the photochemical impact of violet-blue light (405 nm) on ex vivo platelet concentrates (2023)
    Metabolomics 5 citations DOI OpenAlex
  • Prediction and Experimental Evaluation of the hERG Blocking Potential of Drugs Showing Clinical Signs of Cardiotoxicity (2022)
    Letters in Drug Design & Discovery 1 citation DOI OpenAlex
  • Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management (2022)
    Metabolomics 207 citations DOI OpenAlex
  • Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs (2022)
    Toxicological Sciences 6 citations DOI OpenAlex
  • Evaluating Cefoperazone-Induced Gut Metabolic Functional Changes in MR1-Deficient Mice (2022)
    Metabolites 4 citations DOI OpenAlex
  • Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC) (2022)
    Metabolomics 136 citations DOI OpenAlex
  • Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy (2021)
    Journal of Chromatography B 17 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

581 Collaborators 242 Institutions 31 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics